Chad Bello
Finanzdirektor/CFO bei Prolexys Pharmaceuticals, Inc.
Aktive Positionen von Chad Bello
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Finanzdirektor/CFO | 01.01.2002 | - |
Karriereverlauf von Chad Bello
Ehemalige bekannte Positionen von Chad Bello
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Porter & Associates
Porter & Associates Publishing: Books/MagazinesConsumer Services Part of Ascend Learning LLC, Porter & Associates is a publisher of pocket guides for healthcare professionals and institutions. Porter & Associates was acquired by Jones & Bartlett Publishers, Inc. on April 19, 2006. | Comptroller/Controller/Auditor | - | - |
Ausbildung von Chad Bello
University of Utah | Undergraduate Degree |
Westminster College (Utah) | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Director of Finance/CFO | 1 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Health Technology |
Porter & Associates
Porter & Associates Publishing: Books/MagazinesConsumer Services Part of Ascend Learning LLC, Porter & Associates is a publisher of pocket guides for healthcare professionals and institutions. Porter & Associates was acquired by Jones & Bartlett Publishers, Inc. on April 19, 2006. | Consumer Services |
- Börse
- Insiders
- Chad Bello
- Erfahrung